Portfolio
3
companies
Cyted Health
Cyted Health develops gastrointestinal molecular diagnostics for early esophageal disease detection.
FundamentalVR
FundamentalVR provides an immersive simulation platform for surgical training.
Phagenesis
Phagenesis develops neurostimulation technology to treat swallowing disorders.
Bruno Holthof
Partner
Drew Burdon
Partner
Drew is a partner at EQT Life Sciences and serves on the boards of several companies, including FundamentalVR and Neurent Medical.
LinkedInThe financing round was led by EQT Life Sciences alongside co-leads Advent Life Sciences and British Business Bank.
"This Series B financing marks a defining moment for Cyted as we continue to deepen our commitment to detecting esophageal diseases earlier. This investment will help us consolidate our leading position in the market by expanding our US presence and adding new life-saving innovations to our advanced diagnostics portfolio."
The equity round was led by EQT Life Sciences and Sectoral to support international expansion and clinical trials.
"Dysphagia is a severe medical condition that affects countless patients in hospital. It can increase hospital length of stay, the risk of complications, and lengthens recovery time. The Phagenyx System demonstrates significant reductions in hospital length of stay, with a corresponding and substantial reduction in healthcare costs, as evidenced by the Company’s strong portfolio of high-quality clinical studies. This is strongly aligned with EQT’s Health Economics strategy of transforming cutting-edge scientific innovation into impactful and cost-effective healthcare solutions. We‘re excited to support the next phase of Phagenesis’ journey."
The London-based immersive simulation platform has raised $20m to accelerate medical skill transfer and grow in the United States.
"With increasingly complex surgical procedures, it is important to provide medical professionals with new methods for surgical skills transfer and continued training and education while managing both the cost and time burden associated with these activities,"
